01:48 PM EST, 01/02/2025 (MT Newswires) -- Pfizer ( PFE ) is collaborating with Atavistik Bio to accelerate the discovery of new precision allosteric therapeutics, Atavistik said Thursday.

Financial terms of the partnership were not disclosed.

Under the research partnership, the companies will use Atavistik's AMPS platform to identify allosteric binders against two undisclosed targets picked by Pfizer ( PFE ), according to Atavistik.

The collaboration grants Pfizer ( PFE ) the option to license the programs at the end of the research period, Atavistik added.

Price: 26.61, Change: +0.08, Percent Change: +0.30